Your browser doesn't support javascript.
loading
Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat.
Rossini, Anna; Zunino, Franco; Ruggiero, Giusi; De Cesare, Michelandrea; Cominetti, Denis; Tortoreto, Monica; Lanzi, Cinzia; Cassinelli, Giuliana; Zappasodi, Roberta; Tripodo, Claudio; Gulino, Alessandro; Zaffaroni, Nadia; Di Nicola, Massimo.
Afiliação
  • Rossini A; Unit of Immunotherapy and Anticancer Innovative Therapeutics, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Zunino F; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Ruggiero G; Unit of Immunotherapy and Anticancer Innovative Therapeutics, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • De Cesare M; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Cominetti D; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Tortoreto M; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Lanzi C; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Cassinelli G; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Zappasodi R; Unit of Immunotherapy and Anticancer Innovative Therapeutics, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Tripodo C; Tumor Immunology Unit, Department of Health Science, Human Pathology Section, University of Palermo, School of Medicine, Palermo, Italy.
  • Gulino A; Tumor Immunology Unit, Department of Health Science, Human Pathology Section, University of Palermo, School of Medicine, Palermo, Italy.
  • Zaffaroni N; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Di Nicola M; Unit of Immunotherapy and Anticancer Innovative Therapeutics, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Hematol Oncol ; 36(1): 360-362, 2018 Feb.
Article em En | MEDLINE | ID: mdl-28730742
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores Enzimáticos / Microambiente Tumoral / Glucuronidase / Linfoma / Proteínas de Neoplasias Limite: Animals / Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores Enzimáticos / Microambiente Tumoral / Glucuronidase / Linfoma / Proteínas de Neoplasias Limite: Animals / Humans Idioma: En Revista: Hematol Oncol Ano de publicação: 2018 Tipo de documento: Article